“Where the spirit of science is ruling, great things are being done by small means.”

N.I. Pirogov

Research, to a large extent, determines the progress of medical science because it is owing to the research activity that the development of new methods of treatment and more potent drugs becomes possible. This allows the struggle against the most dangerous diseases to become more effective. Scientific activity has always been one of the top priorities of our University; our research embraces the main medical fields, including oncology, pharmacology, hematology and transplantation, molecular genetics, cardiology and cardiac surgery, pulmonology, nephrology, etc.

Pavlov First Saint Petersburg State Medical University is a home to the following Institutes and Institutes for Scientific Research:
• Nephrology Research Institute
• Research Institute of Pulmonology
• Raisa Gorbacheva Memorial Research Institute of Children Oncology, Hematology and Transplantation
• Maxillo-facial Surgery and Dentistry Research Institute
• Valdman Institute of Pharmacology
• Heart and Vascular Research Institute
• Neurology Research Institute
• Research Institute for Surgery and Emergency Medicine
• Research Institute of interstitial and orphan lung diseases
• Research Institute of Rheumatology and Allergology

and Research Centers:
• Scientific Research Center
• Center of Laser Medicine
• Scientific and Methodological Center for Molecular Medicine of the Ministry of Health Care of the Russian Federation
• Centre of early phases of clinical trials
• Research Centre for Anesthesiology and Intensive Care
• Research Centre of Bioinformatics

Scientific journals published by Pavlov University

  1. Cellular Therapy and Transplantation (OA)
  2. Grekov's Bulletin of Surgery (OA)
  3. Regional blood circulation and microcirculation (OA)
  4. The Scientific Notes of the Pavlov University (OA)  

 

Our scientists are engaged in research aimed at improving the diagnosis and treatment of cardiovascular diseases, studying nonspecific chronic lung diseases, increasing the safety and efficacy of pharmacotherapy, designing new drugs that are more efficacious, safer and better tolerated than older medications, etc.

 

Publisher policies 

General information and contacts

Research ethics and consent

Peer review

Competing interests

Misconduct in publications